Literature DB >> 16965622

Immunohistochemical localization patterns for vimentin and other intermediate filaments in calcified ovarian fibrothecoma.

Eric Scott Sills1, Terrence B Doan, R James Mock, George R Dixson, Michael B Rohlfing.   

Abstract

PROBLEM: To describe immunohistochemical features encountered in ovarian fibrothecoma with correlation to clinical presentation and surgical management. METHOD OF STUDY: A female age 75 presented for evaluation of melena. The patient reported total abdominal hysterectomy and removal of both ovaries 40 years earlier.
RESULTS: CA-125 was normal and there was no evidence of hyperestrogen effect. Pelvic CT revealed a partially calcified 7 cm pelvic mass without adenopathy or ascites; ultrasound was confirmatory. Endoscopy identified three benign intestinal tubular adenomas. Following laparoscopic excision of the pelvic tumor immunohistochemical analysis of the mass showed negative staining for keratin, S100 protein, inhibin, calretinin, melan A, smooth muscle actin, CD34, CD117, and desmin. The tissue was positive for vimentin, however.
CONCLUSION: Ovarian fibrothecomas represent an ovarian stromal neoplasm developing in a wide spectrum of clinical settings. Particularly if oophorectomy is stated to have been performed remote from the time of index presentation, the status of the ovaries must be considered whenever pelvic pathology is encountered. We describe a calcified ovarian fibrothecoma identified during gastroenterology investigation and confirmed immunohistochemically via high amplitude vimentin signal.

Entities:  

Year:  2006        PMID: 16965622      PMCID: PMC1570478          DOI: 10.1186/1746-1596-1-28

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  9 in total

1.  A right ovarian mass in a 71-year-old woman with ascites and elevated CA 125 level. Fibrothecoma of the right ovary.

Authors:  Ronald M Angeles; Fadi L Salem; Ronald L Sirota
Journal:  Arch Pathol Lab Med       Date:  2005-05       Impact factor: 5.534

2.  Sclerosing stromal tumor of the ovary. Immunohistochemical and electron-microscopic demonstration of smooth-muscle differentiation.

Authors:  A Saitoh; Y Tsutsumi; R Y Osamura; K Watanabe
Journal:  Arch Pathol Lab Med       Date:  1989-04       Impact factor: 5.534

3.  Ovarian fibrothecoma: sonographic and histologic findings.

Authors:  M Conte; L Guariglia; P Benedetti Panici; G Scambia; C Rabitti; A Capelli; S Mancuso
Journal:  Gynecol Obstet Invest       Date:  1991       Impact factor: 2.031

4.  [Clinical analysis of benign pelvic mass with high serum levels of CA(125)].

Authors:  Xin Zhang; Ling-ying Wu; Xiao-jiang Li; Hong-jun Li; Rong Zhang; Li-ying Liu
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2005-03

5.  Ovarian remnant syndrome.

Authors:  M J Webb
Journal:  Aust N Z J Obstet Gynaecol       Date:  1989-11       Impact factor: 2.100

6.  Ovarian fibrothecoma with massive edema.

Authors:  M Sakaki; M Hirokawa; H Horiguchi; S Wakatsuki; T Sano; Y Izumi
Journal:  J Med Invest       Date:  2000-08

7.  Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.

Authors:  S Kawauchi; T Tsuji; T Kaku; T Kamura; H Nakano; M Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  1998-01       Impact factor: 6.394

8.  Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors.

Authors:  M J Costa; R Morris; P B DeRose; C Cohen
Journal:  Arch Pathol Lab Med       Date:  1993-08       Impact factor: 5.534

9.  Ovarian thecoma associated in the first trimester of pregnancy.

Authors:  Ikuko Okada; Shoko Nakagawa; Yuriko Takemura; Takashi Takenobu; Tatsunari Matsuoka; Hiroyuki Mandai; Tadashi Takemura
Journal:  J Obstet Gynaecol Res       Date:  2004-10       Impact factor: 1.730

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.